Lipoprotein(a) screening in patients with controlled traditional risk factors undergoing percutaneous coronary intervention

When screened judiciously, elevated levels of Lp(a) are highly prevalent in high cardiovascular risk patients, including at a young age, presenting for PCI and may contribute to previously unappreciated residual cardiovascular risk.